Skip to main content
Home - European Commission
Svenska
sv
Dialog
Select your language
Български
Čeština
Dansk
Deutsch
Eesti
Ελληνικά
English
Español
Français
Hrvatski
Gaeilge
Italiano
Latviešu
Lietuvių
Magyar
Malti
Nederlands
Polski
Português
Română
Suomi
Slovenčina
Slovenščina
Svenska
Close
Search this website
Sök
Hem
Bo, jobba och resa i EU
Folkhälsa
Humanläkemedel
Humanläkemedel
Alla ämnen
Medicinal products
EU:s folkhälsopolitik
Folkhälsostrategi
State of Health in the EU
Strukturfonderna och folkhälsa
EU i världen
Hälsoindikatorer
Improving health systems
Vård utomlands
European Reference Networks
E-hälsa
Utvärdering av medicinska metoder
Hälso- och sjukvårdspersonal
Health systems performance assessment
Expert Panel on effective ways of investing in health
Hälsofrämjande insatser
Tobak
Kost och fysisk aktivitet
Alkohol
Sociala faktorer och jämlik hälsa
Medical devices
Medical Devices - Sector
Medical Devices - New regulations
Medical Devices - Topics of Interest
Medical Devices - Dialogue between interested parties
Medical Devices - Expert Panels
Medical Devices - EUDAMED
Substances of human origin
Blod, vävnader och organ
Läkemedel
Humanläkemedel
EudraLex
Union Register
Pharmaceutical committee and expert groups
European Medicines Agency (EMA)
Insatser mot sjukdomar
Health security and infectious diseases
European Centre for Disease Prevention and Control (ECDC)
Vaccinationer
Antibiotikaresistens
Folksjukdomar
Cancer
Riskbedömning
Vetenskapliga kommittéer
Endocrine disruptors
Endocrine disruptors
Biocides
Biocides
Nytt på sajten
12 april 2021
Summary record - 93rd meeting of the Pharmaceutical Committee (17 and 22 February 2021)
30 Mars 2021
updated - A pharmaceutical strategy for Europe
17 Mars 2021
Presentations - EC-DG SANTE/HMA-CTFG/EMA joint training on the Clinical Trials Regulation (EU) 536/2014 (9-10 March 2021)
05 Mars 2021
Notice on handling of duplicate marketing authorisation applications (March 2021)
05 Mars 2021
Summary report: Targeted stakeholder consultation on duplicate marketing authorisations for biological medicinal products
04 Mars 2021
Pharmaceutical Strategy for Europe - Pilot project ‘Market launch of Centrally Authorised Medicinal Products’
26 februari 2021
European Health Union: Commission launches a “structured dialogue” to address vulnerabilities in the supply of medicines in the EU
24 februari 2021
Draft - Questions and Answers Document - Regulation (EU) 536/2014 – Version 3 (February 2021)
11 februari 2021
Agenda - 93rd meeting of the Pharmaceutical Committee (17 and 22 February 2021)
09 februari 2021
Summary record - 92nd meeting of the Pharmaceutical Committee (11 December 2020)
Pages
1
2
3
4
5
6
7
8
9
next ›
last »
Nyhetsbrev
Nyhetsbrev
Nyhetsbrev
Wed, 03/31/2021
Ny livsmedelsförordning ger bättre insyn i riskbedömningar
Nytt på sajten
Summary record - 93rd meeting of the Pharmaceutical Committee (17 and 22 February 2021)
Utlagt
12 april 2021
updated - A pharmaceutical strategy for Europe
Utlagt
30 Mars 2021
Presentations - EC-DG SANTE/HMA-CTFG/EMA joint training on the Clinical Trials Regulation (EU) 536/2014 (9-10 March 2021)
Utlagt
17 Mars 2021
Följ oss på Twitter
Mer
I fokus
Pharmaceutical Strategy for Europe
Structured dialogue on security of medicines supply
Revision of the legislation on orphan and paediatric medicines
Mer information
Pressmaterial
Videoklipp
Eurobarometrar
Evenemang
Samråd
Publikationer
